About
Miracor Medical SA is a Belgium-based medical device company dedicated to developing innovative solutions for severe cardiac diseases. Founded in 2008 and headquartered in Awans, the company focuses on improving clinical outcomes and reducing healthcare costs. With a small team of fewer than 25 employees, Miracor has successfully raised significant funding, including a recent €24 million Series E round. The company's core product is the PiCSO (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System, designed for patients experiencing acute myocardial infarction (AMI). This technology works by intermittently occluding the coronary sinus to enhance blood flow to affected heart tissue, helping to reduce infarct size and improve cardiac function. The PiCSO system includes a driving console and specialized catheters, providing interventional cardiologists with a new therapeutic option for patient recovery. The system is CE-marked and is currently undergoing post-market clinical trials to further validate its safety and effectiveness. Miracor Medical serves hospitals, cardiology centers, and healthcare providers focused on interventional cardiology and acute cardiac care.
Technologies
Keywords
Company Information
-
Employees 7
-
Founded 2008
-
Annual Revenue $10000000
-
Total Funding $87356434
Location
Rue de Bruxelles, Awans, Walloon Region, Belgium, 4342